remdesivir Archives - Page 4 of 5 -

The first doses of Gilead’s COVID-19 drug remdesivir are set to arrive in US hospitals this week after

First doses of Gilead’s COVID-19 drug remdesivir to arrive at US hospitals

https://pharmaphorum.com/news/first-doses-of-covid-19-drug-set-to-arrive-at-us-hospitals/

Covid-19 drug will be ‘affordable’ says Gilead, as it plans to ramp up production

Richard Staines coronavirus, COVID-19, Gilead, R&D, remdesivir 0 Comment

Gilead has outlined its plans to develop and ramp up production of its remdesivir COVID-19 drug, with CEO Daniel O’Day pledging to

Covid-19 drug will be ‘affordable’ says Gilead, as it plans to ramp up production

https://pharmaphorum.com/news/covid-19-drug-will-be-affordable-says-gilead-as-it-plans-to-ramp-up-production/

News/ Top stories

Gilead’s remdesivir hailed as COVID-19 standard of care after trial success

Richard Staines coronavirus, COVID-19, Gilead, remdesivir 0 Comment

It’s official – Gilead’s remdesivir helps severely ill patients recover faster from COVID-19, according to results from a

Gilead’s remdesivir hailed as COVID-19 standard of care after trial success

https://pharmaphorum.com/news/phase-3-trial-confirms-five-day-dosing-regimen-for-gileads-covid-19-drug/

News/ News/ R&D

Disputed COVID-19 trial failure reports send Gilead shares down

Richard Staines coronavirus, COVID-19, Gilead, R&D, remdesivir 0 Comment

Gilead’s COVID-19 drug remdesivir seemingly failed to produce an effect according to results of a Chinese clinical trial

Disputed COVID-19 trial failure reports send Gilead shares down

https://pharmaphorum.com/news/disputed-covid-19-trial-failure-reports-send-gilead-shares-down/

News/ News/ R&D

Gilead shares jump after rethink of COVID-19 remdesivir trial

Richard Staines coronavirus, COVID-19, Gilead, R&D, remdesivir 0 Comment

Shares in Gilead were up in premarket trading after the company announced it had increased the size of

Gilead shares jump after rethink of COVID-19 remdesivir trial

https://pharmaphorum.com/news/gilead-shares-jump-following-covid-19-trial-rethink/

News/ News/ R&D

Gilead slides as second Chinese trial of remdesivir is stopped

Phil Taylor clinical trial, coronavirus, Gilead Sciences, infectious disease, remdesivir 0 Comment

Two investigator-led phase 3 trials of Gilead Sciences’ coronavirus candidate remdesivir have now been halted because they weren’t

Gilead slides as second Chinese trial of remdesivir is stopped

https://pharmaphorum.com/news/gilead-slides-as-two-chinese-trials-of-remdesivir-are-stopped/

News/ News/ News/ Patients/ R&D/ Top stories

First study of Gilead’s remdesivir in COVID-19 reveals little

Phil Taylor clinical trial, coronavirus, Gilead Sciences, remdesivir 0 Comment

Two-thirds of coronavirus patients treated with Gilead’s antiviral drug remdesivir seemed to get a clinical benefit from the

First study of Gilead’s remdesivir in COVID-19 reveals little

https://pharmaphorum.com/news/first-study-of-gileads-remdesivir-in-covid-19-reveals-little/

News/ News/ News/ Patients/ R&D

EMA clears compassionate use of Gilead’s remdesivir for COVID-19

Phil Taylor coronavirus, Gilead Sciences, infectious disease, remdesivir 0 Comment

The EU drugs regulator says Gilead Sciences’ antiviral drug remdesivir should be made available for people seriously ill

EMA clears compassionate use of Gilead’s remdesivir for COVID-19

https://pharmaphorum.com/news/ema-clears-compassionate-use-of-gileads-remdesivir-for-covid-19/

News/ News/ R&D

Gilead halts ‘compassionate use’ of potential coronavirus drug

Richard Staines coronavirus, COVID-19, Gilead, infectious diseases, R&D, remdesivir 0 Comment

Gilead has said it has stopped accepting “compassionate use” requests for its potential coronavirus antiviral remdesivir because it

Gilead halts ‘compassionate use’ of potential coronavirus drug

https://pharmaphorum.com/news/gilead-halts-compassionate-use-of-potential-coronavirus-drug/

Trending

remdesivir

Login